TickerFacts.

Yarrow Bioscience, Inc. (YARW): Capital Expenditures

Annual figures by period end, from SEC filings.

$0
Year ended 2025-12-31
$117.0K2023-12-31: $02024-12-31: $117.0K2025-12-31: $0$0
2023-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$0-100.0%2026-02-27, From 2025-01-01
2024-12-31$117.0Kn/a2026-02-27, From 2024-01-01
2023-12-31$0n/a2025-03-06, From 2023-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Yarrow Bioscience, Inc. (YARW)2025-12-31$0-100.0%
Silence Therapeutics plc (SLN)2025-12-31$55.0K-73.9%
PMGC Holdings Inc. (ELAB)2025-12-31$442.3Kn/m
Vaccinex, Inc. (VCNX)2024-12-31$22.0K-67.2%
Quantum Cyber N.V. (QUCY)2025-12-31$1.2K-98.8%
BioXcel Therapeutics, Inc. (BTAIQ)2025-12-31$0n/a
Polomar Health Services, Inc. (PMHS)2024-12-31$90.9Kn/a
Mereo BioPharma Group plc (MREO)2025-12-31$20.0Kn/a
Lexaria Bioscience Corp. (LEXX)2025-08-31$24.6K-42.7%

Compare YARW, SLN, ELAB, VCNX side by side · Screen every company in Pharmaceutical Preparations ↗